Evidence map›Paper›PMID 39746913›Full record

ArticleNature communications2025

Mms22-Rtt107 axis attenuates the DNA damage checkpoint and the stability of the Rad9 checkpoint mediator.

Bingbing Wan, Danying Guan, Shibai Li, Tzippora Chwat-Edelstein, Xiaolan Zhao

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Bingbing Wan *Key Laboratory of Systems Biomedicine (Ministry of Education), Shanghai Center for Systems Biomedicine, Shanghai Jiao Tong University, Shanghai, 200240, China. wanb@sjtu.edu.cn.ORCID 0000-0001-8629-0616
Danying Guan *Molecular Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID 0000-0002-3888-8047
Shibai LiMolecular Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID 0000-0001-9293-6006
Tzippora Chwat-EdelsteinMolecular Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Xiaolan ZhaoMolecular Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA. zhaox1@mskcc.org.ORCID 0000-0002-8302-6905

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI SELWYN M VICKERS · 1985 to 2026
$347.4M
Regulation of genome replication, recombination, and stress responseR35GM145260 · NIGMS · SLOAN-KETTERING INST CAN RESEARCH · PI Xiaolan Zhao · 2022 to 2026
$3.6M
National Natural Science Foundation of China (National Science Foundation of China) 32170087NCI NIH HHS P30 CA008748NIGMS NIH HHS R35 GM145260U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) R35GM145260
6 · The paper itself

Abstract

The DNA damage checkpoint is a highly conserved signaling pathway induced by genotoxin exposure or endogenous genome stress. It alters many cellular processes such as arresting the cell cycle progression and increasing DNA repair capacities. However, cells can downregulate the checkpoint after prolonged stress exposure to allow continued growth and alternative repair. Strategies that can dampen the DNA damage checkpoint are not well understood. Here, we report that budding yeast employs a pathway composed of the scaffold protein Rtt107, its binding partner Mms22, and an Mms22-associated ubiquitin ligase complex to downregulate the DNA damage checkpoint. Mechanistically, this pathway promotes the proteasomal degradation of a key checkpoint factor, Rad9. Furthermore, Rtt107 binding to Mms22 helps to enrich the ubiquitin ligase complex on chromatin for targeting the chromatin-bound form of Rad9. Finally, we provide evidence that the Rtt107-Mms22 axis operates in parallel with the Rtt107-Slx4 axis, which displaces Rad9 from chromatin. We thus propose that Rtt107 enables a bifurcated "anti-Rad9" strategy to optimally downregulate the DNA damage checkpoint.

Indexed as

Cell Cycle ProteinsChromatinDNA DamageSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsCell Cycle CheckpointsDNA-Binding ProteinsDNA RepairEndodeoxyribonucleasesNuclear ProteinsSignal TransductionUbiquitin-Protein LigasesCell Cycle ProteinsChromatinDNA-Binding ProteinsEndodeoxyribonucleasesMms22 protein, S cerevisiaeNuclear Proteinsrad9 proteinRTT107 protein, S cerevisiaeSaccharomyces cerevisiae ProteinsSLX4 protein, S cerevisiaeUbiquitin-Protein Ligases

Identifiers

PMID39746913
PMCPMC11697250

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.